Received Feb 10, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
The patient started with the Dementia symptoms; This spontaneous case was reported by a consumer and describes the occurrence of DEMENTIA (The patient started with the Dementia symptoms) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced DEMENTIA (The patient started with the Dementia symptoms) (seriousness criterion medically significant). At the time of the report, DEMENTIA (The patient started with the Dementia symptoms) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) was unknown. No concomitant medications were provided. It was asked by the reported that the covid vaccine was told to take back in 2020 was the cause of Dementia. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was provided.; Reporter's Comments: Company Comment: The benefit-risk relationship of the product is not affected by this report.